Adial - Volume dana dhuwit perusahaan ADIL

The cash balance reflects current liquidity, with the current level standing at 0.03. The firm's environmental policy is limited to basic waste disposal. Adial Pharmaceuticals strengthens its image through its status as an innovator in precision addiction therapy. However, business sustainability depends on the outcome of final tests for the lead drug and regulatory approval, given the absence of other revenue streams.
Rincian metrik lan analitis perusahaan Adial Pharmaceuticals (ADIL)

This indicator tracks the volume of liquid assets, determining the issuer's ability to service obligations without seeking external financing. The trend is driven by the difference between operating cash flows and capital expenditures. By analyzing the structure of cash balances, an investor assesses the business's margin of safety. For Adial Pharmaceuticals (ADIL), such reserves are critical when introducing the AD04 drug into clinical practice. Sufficient capital ensures the development of the addiction therapy ecosystem.